Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-CDC37 Antibody (R3U35)

Catalog #:   RHH28505 Specific References (26) DATASHEET
Host species: Mouse
Isotype: IgG2a
Applications: ELISA, FCM, WB
Accession: Q16543
Overview

Catalog No.

RHH28505

Species reactivity

Human, Mouse

Host species

Mouse

Isotype

IgG2a

Clonality

Monoclonal

Tested applications

ELISA: 1:10000, FCM: 1:200-1:400, WB: 1:500-1:2000

Target

CDC37, Hsp90 co-chaperone Cdc37, Hsp90 chaperone protein kinase-targeting subunit, p50Cdc37, CDC37A

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

Q16543

Applications

ELISA, FCM, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% Sodium Azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

R3U35

Data Image
  • Flow Cytometry
    Flow cytometric analysis of K562 cells using CDC37 mouse mAb (green) and negative control (red).
  • Western blot
    Western blot analysis using CDC37 mouse mAb against K562 (1), LNcap (2), A431 (3), HEK293 (4), and C2C12 (5) cell lysate.
References

Predictive value of CDC37 gene expression for targeted therapy in metastatic colorectal cancer., PMID:38359495

Phosphatases maintain low catalytic activity of SGK1: DNA damage resets the balance in favor of phosphorylation., PMID:37343701

Th1 cytokine interferon gamma improves response in HER2 breast cancer by modulating the ubiquitin proteasomal pathway., PMID:33412308

SUMOylation Is Required for ERK5 Nuclear Translocation and ERK5-Mediated Cancer Cell Proliferation., PMID:32209980

DCZ3112, a novel Hsp90 inhibitor, exerts potent antitumor activity against HER2-positive breast cancer through disruption of Hsp90-Cdc37 interaction., PMID:30017966

Ganetespib for small cell lung cancer., PMID:27922280

Simultaneous blockade of interacting CK2 and EGFR pathways by tumor-targeting nanobioconjugates increases therapeutic efficacy against glioblastoma multiforme., PMID:27825958

Targeting HSF1 disrupts HSP90 chaperone function in chronic lymphocytic leukemia., PMID:26397138

Protein kinase CK2 inhibition is associated with the destabilization of HIF-1α in human cancer cells., PMID:25449433

IP-FCM platform detects the existence and regulator-caused dissociation of components in naturally assembled HSP90 complex., PMID:24265268

Hsp90, an unlikely ally in the war on cancer., PMID:23356585

Cell surface Cdc37 participates in extracellular HSP90 mediated cancer cell invasion., PMID:22912728

Serum IgG responses against Aspergillus proteins before hematopoietic stem cell transplantation or chemotherapy identify patients who develop invasive aspergillosis., PMID:22824184

Constitutively active Lck kinase in T cells drives antigen receptor signal transduction., PMID:20541955

Split Renilla luciferase protein fragment-assisted complementation (SRL-PFAC) to characterize Hsp90-Cdc37 complex and identify critical residues in protein/protein interactions., PMID:20413594

Hsp90-dependent activation of protein kinases is regulated by chaperone-targeted dephosphorylation of Cdc37., PMID:18922470

Evaluating CK2 activity with the antibody specific for the CK2-phosphorylated form of a kinase-targeting cochaperone Cdc37., PMID:18566753

Analysis of the CK2-dependent phosphorylation of serine 13 in Cdc37 using a phospho-specific antibody and phospho-affinity gel electrophoresis., PMID:17922836

The platelet-derived growth factor receptor alpha is destabilized by geldanamycins in cancer cells., PMID:17079230

Effect of single wall carbon nanotubes on human HEK293 cells., PMID:15585362

Identification of transcription coactivator OCA-B-dependent genes involved in antigen-dependent B cell differentiation by cDNA array analyses., PMID:12857960

Interaction of Hsp90 with the nascent form of the mutant epidermal growth factor receptor EGFRvIII., PMID:12471035

Molecular characterization of a novel intracellular hyaluronan-binding protein., PMID:10887182

p50(cdc37) is a nonexclusive Hsp90 cohort which participates intimately in Hsp90-mediated folding of immature kinase molecules., PMID:10858314

A 50 kilodalton protein associated with raf and pp60(v-src) protein kinases is a mammalian homolog of the cell cycle control protein cdc37., PMID:9132011

A novel glycosaminoglycan-binding protein is the vertebrate homologue of the cell cycle control protein, Cdc37., PMID:7608185

Datasheet

Document Download

Anti-CDC37 Antibody (R3U35).pdf

 

$ 220
Product specifications
50 μg 220 100 μg 350

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-CDC37 Antibody (R3U35) [RHH28505]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only